FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2004-02-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BBRC.2003.12.102PMID 14733920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Autosomal Dominant Hypophosphatemic Rickets R176Q Mutation in Fibroblast Growth Factor 23 Resists Proteolytic Cleavage and Enhances in Vivo Biological Potency*

  2003cited by this paper
• Vitamin D and its analogs as regulators of immune activation and antigen presentation.

  2003cited by this paper
• Vitamin D and autoimmune diabetes

  2003cited by this paper
• FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

  2003cited by this paper
• Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice

  2001cited by this paper
• Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction

  2001cited by this paper
• The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

  2001cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteomalacia in Hyp Mice Is Associated with Abnormal Phex Expression and with Altered Bone Matrix Protein Expression and Deposition*

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• PHEX gene and hypophosphatemia.

  2000cited by this paper
• Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter.

  1998cited by this paper
• Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.

  1998cited by this paper
• Cellular/molecular control of renal Na/Pi-cotransport.

  1998cited by this paper
• Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.

  1997cited by this paper
• Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

  1997cited by this paper
• Principles of Bone Biology

  1996cited by this paper
• A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets

  1995cited by this paper
• Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules.

  1995cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper

• Comparison of Serum FGF23 Levels and CKD-MBD Parameters in Home Hemodialysis and Center Hemodialysis

  2025cites this paper
• Association between Serum Glycerol-3-Phosphate and Fibroblast Growth Factor-23 in Nondiabetic Patients on Hemodialysis.

  2025cites this paper
• Bone and muscle crosstalk in ageing and disease

  2025cites this paper
• Aging: a Struggle for Beneficial to Overcome Negative Factors made by Muscle and Bone.

  2025cites this paper
• Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs

  2025cites this paper
• Bone mineralization and the effects of elevated osteopontin: from symmetry-breaking foci to 3D space-filling tessellation

  2025cites this paper
• Asymmetric FGF Receptor Dimerization: Implications for FGF23 Biology and Drug Discovery.

  2025cites this paper
• Advances in noninvasive diagnosis of renal osteodystrophy

  2025cites this paper
• SARS-CoV-2 and its Multifaceted Impact on Bone Health: Mechanisms and Clinical Evidence

  2024cites this paper
• The Ip6k1 and Ip6k2 Kinases Are Critical for Normal Renal Tubular Function

  2024cites this paper
• Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity

  2024influential citation
• The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23

  2024cites this paper
• COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions

  2024cites this paper
• Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis

  2023cites this paper
• NT‐proBNP Mediates the Association Between FGF23 and All‐Cause Mortality in Individuals With Type 2 Diabetes

  2023cites this paper
• Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis.

  2023cites this paper
• Diagnosis and management of tumor-induced osteomalacia: a single center experience

  2023cites this paper
• Fibroblast growth factor 23, klotho and heparin

  2023cites this paper
• Targeting aging with the healthy skeletal system: The endocrine role of bone

  2023cites this paper
• Safety and efficacy of the pan-FGFR inhibitor erdafitinib in advanced urothelial carcinoma and other solid tumors: A systematic review and meta-analysis

  2023cites this paper
• Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves' ophthalmopathy in comparison to hyperthyroid patients without Graves' ophthalmopathy.

  2023cites this paper
• Insights into the Molecular and Hormonal Regulation of Complications of X-Linked Hypophosphatemia

  2023cites this paper
• Genome-wide analyses of gene expression profile identify key genes and pathways involved in skeletal response to phosphate and 1,25-dihydroxyvitamin D3 in vivo.

  2023cites this paper
• Crosstalk between bone and muscle in chronic kidney disease

  2023cites this paper
• Impact of X-Linked Hypophosphatemia on Muscle Symptoms

  2022cites this paper
• Vitamin D

  2022cites this paper
• FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease

  2022cites this paper
• In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study

  2022cites this paper
• (Pro)renin Receptor Regulates Phosphate Homeostasis in Rats via Releasing Fibroblast Growth Factor-23

  2022cites this paper
• Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System

  2022cites this paper
• Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.

  2022cites this paper
• The impact of uremic toxins on Alzheimer's disease.

  2022cites this paper
• Complications and Treatments in Adult X-Linked Hypophosphatemia

  2022cites this paper
• Interactions between FGF23 and vitamin D

  2022cites this paper
• Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy

  2022cites this paper
• Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells

  2022cites this paper
• Vitamin D in kidney disease

  2022cites this paper
• TUMOR-INDUCED OSTEOMALACIA: A COMPREHENSIVE REVIEW.

  2022cites this paper
• Endocrine Fibroblast Growth Factors in Relation to Stress Signaling

  2022cites this paper
• Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia Versus X-linked Hypophosphatemia in Chinese Adolescents

  2022cites this paper
• Osteoporosis associated with chronic kidney disease

  2021cites this paper
• Vitamin D Metabolism or Action

  2021cites this paper
• CKD-MBD und sekundärer Hyperparathyreoidismus (Teil 1)

  2021influential citation
• FGF23 and Vitamin D Metabolism

  2021cites this paper
• FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes

  2021cites this paper
• A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 1: Physiology of calcium handling.

  2021cites this paper
• FGF23—an established master regulator of phosphate metabolism

  2021cites this paper
• Effects of FGF23 in the distal nephron

  2021cites this paper
• Upstream Regulators of Fibroblast Growth Factor 23

  2021cites this paper
• Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality

  2021cites this paper
• The bone is the major source of high circulating intact fibroblast growth factor-23 in acute murine polymicrobial sepsis induced by cecum ligation puncture

  2021cites this paper
• Salivary phosphate as a biomarker for human diseases

  2021cites this paper
• In Vivo Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23

  2021cites this paper
• Uremic Toxins and Vascular Dysfunction

  2020cites this paper
• FGF/FGFR signaling in health and disease

  2020cites this paper
• Association Between FGF-23 Levels and Risk of Fracture in Women With Systemic Sclerosis.

  2020cites this paper
• Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging

  2020cites this paper
• Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.

  2020cites this paper
• Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia

  2020cites this paper
• Vitamin-D

  2020cites this paper
• Beyond mineralisation: metabolic functions for matrix mineralisation regulators.

  2020cites this paper
• High-Phosphate Diet Improved the Skeletal Development of Fam20c-Deficient Mice

  2020cites this paper
• Pathophysiology of The Chronic Kidney Disease–Mineral Bone Disorder

  2020cites this paper
• FGF Signaling in Cartilage Development and Disease

  2020cites this paper
• Chronic Kidney Disease–Mineral and Bone Disorders

  2020cites this paper
• Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.

  2020cites this paper
• New insights into the role of FGF-23 and Klotho in cardiovascular disease in chronic kidney disease patients.

  2020cites this paper
• Vitamin D supplementation improves bone mineralisation independent of dietary phosphate in male X-linked hypophosphatemic (Hyp) mice.

  2020cites this paper
• Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study

  2019cites this paper
• [Middle-molecule uremic toxins: A renewed interest].

  2019cites this paper
• High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis

  2019cites this paper
• Animal Models of Phosphorus Homeostasis

  2019cites this paper
• Novel glomerular filtration markers.

  2019cites this paper
• Levels of parathyroid hormone and fibroblast growth factor 23 in various stages of pediatric patients with chronic kidney disease

  2019cites this paper
• Regulation and Effects of FGF23 in Chronic Kidney Disease.

  2019cites this paper
• FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function

  2019influential citation
• Bone function, dysfunction and its role in diseases including critical illness

  2019cites this paper
• Roles of Phosphate in Skeleton

  2019cites this paper
• Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.

  2019cites this paper
• FGF23 and Associated Disorders of Phosphate Wasting.

  2019cites this paper
• Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.

  2019cites this paper
• Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• Metastatic prostate cancer presenting as tumour-induced osteomalacia

  2019cites this paper
• Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.

  2019cites this paper
• Vitamin D Activities in Osteocytes

  2018cites this paper
• Clinical Disorders of Phosphate Homeostasis

  2018cites this paper
• Edinburgh Research Explorer New insights into NPP1 function

  2018cites this paper
• The role of Klotho in mineral metabolism and inflammation

  2018cites this paper
• Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

  2018cites this paper
• Journal of Veterinary Internal Medicine, Volume 32, Issue 4:

  2018cites this paper
• Chapter 40 – Heritable Renal Phosphate Wasting Disorders

  2018cites this paper
• Phosphate homeostasis disorders.

  2018cites this paper
• Off-target effects and adverse outcomes of fibroblast growth factor 23 in chronic kidney disease

  2018cites this paper
• Renal Diseases and Skeletal Health

  2018cites this paper
• FGF23 beyond Phosphotropic Hormone.

  2018cites this paper
• Short stature and growth hormone deficiency: unexpected manifestations of McCune-Albright syndrome

  2018cites this paper
• Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease

  2018cites this paper
• Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy

  2018cites this paper
• Phosphate as a Signaling Molecule and Its Sensing Mechanism.

  2018cites this paper